Kuopion yliopistollinen sairaala
Kuopio University Hospital

Julkaisut 2001
Publications 2001

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1	Aalto-Setälä K et al.	Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.
2	Aaltomaa S, Ala-Opas M.	The effects of transurethral needle ablation on symptoms of chronic pelvic pain syndrome.
3	Aaltomaa S et al.	Brakyhoidolla sisäistä säteilyä eturauhaseen.
4	Aaltomaa S et al.	Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer.
5	Aaltomaa SH et al.	Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.
6	Ahonen K et al.	Varhaiskokemukset Integral-varresta (BiometR) Femurin reartroplastioissa.
7	Airaksinen KEJ et al.	Effects of noradrenaline on human vagal baroreflexes.
8	Airaksinen O.	Tulehduskipulääkkeiden tulevaisuus.
9	Airaksinen O.	Selkävaivan hoitoperiaatteet.
10	Airaksinen O.	Hieronnan vaikutukset.
11	Airaksinen O, Kouri JP.	Akupunktuuri kivunhoitomenetelmänä.
12	Airaksinen O et al.	Monitoring of muscle fatigue during isokinetic exercise.
13	Airas U, Heinonen S.	Napanuorasolmun kliininen merkitys obstetriikassa.
14	Ala-Haavisto R.	Di-anoigostinen järjestelmä. Filosofis-teoreettinen diagnostinen käsitteistö hoitotyöhön ja hoitotieteeseen.
15	Alafuzoff I.	Neuropatologinen tutkimus.
16	Alamowitch S et al.	Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis.
17	Alhava E, Viikari J.	Luissa on muitakin sairauksia kuin osteoporoosi.
18	Anderson SD et al.	Laboratory protocol for exercise asthma to evaluate salbutamol given by two devices.
19	Antikainen R.	Tytön salaisuus ja päiväperho.
20	Antikainen R et al.	Mood improvement reduces memory complaints in depressed patients.
21	Appelberg BG et al.	Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
22	Arnala I et al.	Bone histomorphometry in celiac disease.
23	Arokoski JP et al.	Back and abdominal muscle function during stabilization exercises.
24	Arokoski JPA, Lammi MJ.	Glukosamiinisulfaatti nivelrikon hoidossa.
25	Arokoski JPA et al.	Nivelrikon etiopatogeneesi.
26	Arokoski JPA et al.	Osteoporoosin lääkkeetön ehkäisy ja hoito. Oikea ravitsemus ja liikunta elämäntavaksi.
27	Arponen R, Airaksinen O.	Hoitava hieronta.
28	Arponen R, Airaksinen O.	Asiakaslähtöinen hierontatyö.
29	Arponen R, Airaksinen O.	Fysikaaliset hoidot.
30	Arponen R et al.	Hieronnan käyttömahdollisuudet ja soveltaminen.
31	Astuti D et al.	RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
32	Auranen M et al.	MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features.
33	Badra LJ et al.	Respiratory modulation of human autonomic rhythms.
34	Bailey CJ et al.	Transcranial magnetic stimulation as a tool for cognitive studies.
35	Benavente O et al.	Prognosis after transient monocular blindness associated with carotid-artery stenosis.
36	Berg M.	Rintasyövän diagnostiikka radiologian erikoislääkärin näkökulmasta.
37	Berg M et al.	Suolistoiskemian hoito pallolaajennuksella ja stentillä.
38	Bergström KA et al.	Dopamine transporter in vitro binding and in vivo imaging in the brain.
39	Björklund M et al.	Spatial working memory improvement by an alpha2-adrenoceptor agonist dexmedetomidine is not mediated through alpha2C- adrenoceptor.
40	Blomgren K et al.	A prospective study on pros and cons of electrodissection tonsillectomy.
41	Bras APM et al.	Spermidine/spermine N1-acetyltransferase catalyzes amantadine acetylation.
42	Bräsen JH et al.	Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition, and oxidation-specific epitopes in stented human coronary arteries.
43	Butovas S et al.	Differential effect of the alfa2-adrenoceptor antagonist, atipamezole, in limb-placing task and skilled forepaw use following experimental stroke.
44	Böhm J.	Prognosis of Differentiated Thyroid Carcinoma. Relation to Clinical Factors and Cell Adhesion.
45	Callister LC et al.	Giving birth: perceptions of Finnish childbearing women.
46	Campbell BCV et al.	The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia withLewy bodies and Parkinson`s disease.
47	Castrén E, Castrén M.	Hermosolusiirrot neurologisten tautien hoidossa.
48	Castrén M et al.	Subcellular localization of fragile X mental retardation protein with I304N mutation in the RNA-binding domain in cultured hippocampal neurons.
49	Chen Y et al.	Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism.
50	Clarke NA et al.	Tacrine may alter APP-like protein levels in the lumbar CSF of Alzheimer patients.
51	Cohn JN et al.	A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
52	Deprest J et al.	Towards an endoscopic intra-uterine treatment for congenital diaphragmatic hernia: preclinical experimental studies.
53	Devlieger R et al.	Amniodistentie met stikstofoxide versus vocht in een schapenmodel voor foetoscopische chirurgie: invloed op de operatieduur en foetaal zuur-base-evenwicht.
54	Dhingra VK et al.	Attenuation of lung inflammation by adrenergic agonists in murine acute lung injury.
55	Diabetes Atherosclerosis Intervention Study Investigators.	Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomized study.
56	Dickstein K et al.	Comparison of baseline data, initial course, and management: Losartan versus Captopril following acute myocardial infarction (The OPTIMAAL Trial).
57	DiSilvestro MR et al.	Biphasic poroviscoelastic simulation of the unconfined compression of articular cartilage: I-simultaneous prediction of reaction force and lateral displacement.
58	Du AT et al.	Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer´s disease.
59	Dunder U, Mononen I.	Human leukocyte glycosylasparaginase: cell-to-cell transfer and properties in correction of aspartylglycosaminuria.
60	Ebeling F et al.	Factors predicting interferon treatment response in patients with chronic hepatitis C: late viral clearance does not preclude a sustained response.
61	Ebeling H et al.	Somatically expressed psychological distress and alexithymia in adolescence - reflectig unbearable emotions?
62	Elo J et al.	Rohdossa löytyy.
63	Eloniemi-Sulkava U et al.	Effects of supporting community-living demented patients and their caregivers: A randomized trial.
64	Eloranta M-L et al.	Risk of obstetric cholestasis in sisters of index patients.
65	Elovaara I et al.	Immunoglobuliinin käyttö neurologisten tautien hoidossa.
66	Enckell H.	"I want to know, too". Psychoterapy with a visually impaired boy.
67	Enckell H.	Psychic reality and psychoanalysis: a look through the theory of methaphor.
68	Enholm B et al.	Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin.
69	Ensio A.	Hoitotyön toiminnan mallintaminen.
70	Eray M et al.	Flow cytometric analysis of apoptotic subpopulatios with a combination of Annexin V-FITC, propidium iodide, and SYTO 17.
71	Eriksson BI et al.	Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
72	Erkinjuntti T, Pirttilä T.	Vaskulaariset dementiat.
73	Erkinjuntti T et al., toim.	Muistihäiriöt ja dementia.
74	Erkinjuntti T et al.	Muistihäiriöt ja dementia.
75	Erkkilä A.	Diet, Serum Lipids and Serum Lipid Related Risk Factors in Patients with Coronary Heart Disease. A Cross-sectional Study.
76	Erkkilä AT et al.	APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose 1-3.
77	EUROASPIRE I and II Group.	Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries.
78	EUROASPIRE II Study Group.	Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: Principal results from EUROASPIRE II Euro Heart Survey Programme.
79	Everson SA et al.	Stress-induced blood pressure reactivity and incident stroke in middle-aged men.
80	Felszeghy S et al.	The distribution pattern of the hyaluronan receptor CD44 during human tooth development.
81	Finnilä S et al.	Increased risk of sensorineural hearing loss and migraine in patients with a rare mitochondrial DNA variant 4336A>G in tRNA.
82	Finnish Best Practice Guidelines (FBPG) työryhmä et al.	Kroonista munuaisten vajaatoimintaa sairastavien potilaiden anemian hoito.
83	Forss H, Widström E.	From amalgam to composite: selection of restorative materials and restoration longevity in Finland.
84	Golay X et al.	Measurement of tissue oxygen extraction ratios from venous blood T(2): increased precision and validation of principle.
85	Goldstein S et al.	Metoprolol controlled release/extended release in patients with severe heart failure: Analysis of the experience in the MERIT-HF Study.
86	Greaves DR et al.	Linked chromosome 16q13 chemokines, macrophage-derived chemokine, fractalkine, and thymus- and activation-regulated chemokine, are expressed in human atherosclerotic lesions.
87	Grieve R et al.	A comparison of the costs and survival of hospital-admitted stroke patients across Europe.
88	Gröhn OHJ, Kauppinen RA.	Assessment of brain tissue viability in acute ischemic stroke by BOLD NMR.
89	Grönlund-Pakkanen S et al.	Effect of photodynamic therapy on urinary bladder function: an experimental study with rats.
90	Gul HI et al.	Antifungal activity of some mono, bis and quaternary Mannich bases derived from acetophenone.
91	Gylling H, Miettinen TA.	A review of clinical trials in dietary interventions to decrease the incidence of coronary artery disease.
92	Haapala J et al.	Decline after immobilisation and recovery after remobilisation of synovial fluid il1, timp, and chondroitin sulphate levels in young beagle dogs.
93	Haapasalo A et al.	Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival.
94	Hakkola J et al.	Cytochrome P450 3A expression in the human fetal liver: Evidence that CYP3A5 is expressed in only a limited number of fetal livers.
95	Halimaa S-L.	Video recording as a method of data collection in nursing research.
96	Halimaa S-L.	Hoidetaanko keskoslapsen kipua? . Tutkimus hoitajien valmiuksista arvioida ja hoitaa keskoslapsen kipua.
97	Halimaa S-L et al.	Pain relieving measures for prosedural pain in premature babies: an observational study.
98	Halimaa SL et al.	Knowledge, assessment and management of pain related to nursing procedures used with premature babies: questionnaire study for caregivers.
99	Halinen MO.	Ikä ja antikoagulanttihoito.
100	Hallikainen M.	Role of Plant Stanol Ester- and Sterol Ester-Enriched Margarines in the Treatment of Hypercholesterolemia.
101	Halonen T et al.	Effect of lamotrigine treatment on status epilepticus-induced neuronal damage and memory impairment in rat.
102	Halonen T et al.	Chronic elevation of brain GABA levels beginning two days after status epilepticus does not prevent epileptogenesis in rats.
103	Harvima I.	Kroonisten säärihaavojen hoito edellyttää yhteistyötä ja tehokkaita menetelmiä.
104	Heikkilä A et al.	Angiographically guided utero-placental gene transfer in rabbits with adenoviruses, plasmid/liposomes and plasmid/polyethyleneimine complexes.
105	Heikkilä A et al.	Elevated maternal serum hCG in the second trimester increases prematurity rate and need for neonatal intensive care in primiparous preeclamptic pregnancies.
106	Heikkinen JO et al.	Quality of dynamic radionuclide renal imaging: multicentre evaluation using a functional renal phantom.
107	Heikkinen M et al.	Prevalence of gastric metaplasia in the duodenal buld is low in Helicobacter pylori postive non-ulcer dysplasia patients.
108	Heikkinen P et al.	Effects of mobile phone radiation on X-ray-induced tumorigenesis in mice.
109	Heikkinen P et al.	Effects of 50 Hz magnetic fields on cancer induced by ionizing radiation in mice.
110	Heikkinen T, Isola A.	Painehaavaumapotilaat Itä-Suomen läänin hoitolaksien vuodeosastoilla keväällä 1999.
111	Heinonen S et al.	Maternal susceptibility locus for obstetric cholestasis maps to chromosone region 2p13 in finnish patients.
112	Heinonen S et al.	Apolipoprotein E alleles in women with polycystic ovary syndrome.
113	Heinonen S, Saarikoski S.	Reproductive risk factors of fetal asphyxia at delivery: A population based analysis.
114	Heinonen S et al.	Weights of placentae from small-for-gestational age infants revisited.
115	Heiskanen JT et al.	Bone mineral metabolism after total gastrectomy.
116	Heiskanen JT et al.	Insertion-deletion polymorphism in the gene for angiotensin-converting enzyme is associated with obstetric cholestasis but not with preeclampsia.
117	Helenius M et al.	Characterization of aging-associated up-regulation of constitutive nuclear factor-kappaB binding activity.
118	Helin-Tanninen M et al.	Karmelloosigeelin.
119	Helin-Tanninen M et al.	Uudet teknologiat farmasiassa ja potilaiden hoidossa: ESCP:n kongressi, Basel, 11.-14.10.2000.
120	Helin-Tanninen M et al.	Enteral suspension of nifedipine for neonates. Part 2. Stability of an extemporaneously compounded nifedipine suspension.
121	Helin-Tanninen M et al.	Enteral suspension of nifedipine for neonates. Part 1. Formulation of nifedipine suspension for hospital use.
122	Heliö T et al.	Laajentavan kardiomyopatian geenivirheet.
123	Helkala E-L et al.	Associations between apolipoprotein E phenotype, glucose metabolism and cognitive function in men. An explorative study in a population sample.
124	Helminen HJ et al.	Polven ja lonkan nivelrikon ehkäisy - haavettako vain?
125	Heydeck D et al.	Oxidation of LDL by rabbit and human 15-lipoxygenase: prevalence of nonenzymatic reactions.
126	Hietanen A et al.	Kehitystyötä KYS:ssa: Urakehitysohjelma helpottaa osaamisen arviointia.
127	Hietanen M, Hänninen T.	Laaja neuropsykologinen tutkimus.
128	Hiippala A et al.	Fetal nuchal translucency and normal chromosomes: a long-term follow-up study.
129	Hiltunen M et al.	Genome-wide linkage disequilibrium mapping of late-onset Alzheimr´s disease in Finland.
130	Hiltunen M, Soininen H.	Genes, proteins and brain disease.
131	Hiltunen MO et al.	Gene therapy methods in cardiovascular diseases.
132	Hiltunen TP et al.	Rabbit atherosclerotic lesions express scavenger receptor AIII mRNA, a naturally occurring splice variant that encodes a non-functional, dominant negative form of the macrophage scavenger receptor.
133	Hintikka J et al.	Are alexithymia and depression distinct or overlapping constructs? A study in a general population.
134	Hintikka J et al.	Suicidal ideation in the Finnish general population. A 12-month follow-up study.
135	Hippeläinen M.	Endometrioosi.
136	Hippeläinen M et al.	Synnytykseen liittyvän vaikean verenvuodon embolisaatiohoito.
137	Hirvonen A et al.	Polymorphic GSTs and cancer predisposition.
138	Hokkanen L et al.	Kognitiiviset häiriöt ja niiden tutkiminen.
139	Hongisto T.	HB-näytteenotto ja määritys.
140	Honkalampi K.	Studies on the Relationship Between Alexithymia and Depression.
141	honkalampi k.	Aleksitymia ja masentuneisuus.
142	Honkalampi K et al.	Alexithymia in patients with major depressive disorder and comorbid cluster C personality disorders: a 6-month follow-up study.
143	Honkalampi K et al.	Alexithymia and depression. A prospective study of patients with major depressive disorder.
144	Honkalampi K et al.	Why do alexithymic features appear to be stable? A 12-month follow-up study of a general population.
145	Honkalampi K et al.	Does the cellular phone help to communicate when face-to-face contacts are difficult?
146	Honkanen R et al.	Effect of calcium on bone loss and fractures according to estrogen repletion status.
147	Hujakka H et al.	New immunochromatographic rapid test for diagnosis of acute Puumala virus infection.
148	Hurskainen R et al.	Psychosocial and other characteristics of women complaining of menorrhagia, with and without actual increased menstrual blood loss.
149	Hurskainen R et al.	Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy fot treatment of menorrhagia: a randomised trial.
150	Huttunen K et al.	Comparison of mycobacteria-induced cytotoxicity and inflammatory responses in human and mouse cell lines.
151	Huttunen M et al.	Inhibition of keratinocyte growth in cell culture and whole skin culture by mast cell mediators.
152	Huusko TM et al.	Lonkkamurtumapotilaiden kuntoutus Keski-Suomessa.
153	Huusko TM et al.	Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland.
154	Huuskonen J.	Osteoporosis in Men.
155	Huuskonen J et al.	Pamidronate increases trabecular bone mineral density in immobilization osteopenia in male rats.
156	Huuskonen J et al.	Alendronate influences bending force of femoral diaphysis after orchidectomy in rats.
157	Huuskonen J et al.	Regular physical exercise and bone mineral density: a four-year controlled randomized trial in middle-aged men. The DNASCO study.
158	Hyttinen MM et al.	Age matters: collagen birefringeance of superficial articular cartilage is increased in young guinea-pigs but descreased in older animals after idential physiological type of joint loading.
159	Hyttinen MM et al.	Inactivation of one allele of the type II collagen gene alters the collagen network in murine articular cartilage and makes cartilage softer.
160	Häkkinen A et al.	Strength training induced adaptations in neuromuscular function of premenopausal women with fibromyalgia: comparison with healthy women.
161	Häkkinen A et al.	A randomized two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity, and bone mineral density in early rheumatoid arthritis.
162	Häkkinen K et al.	Changes in electromyographic activity, muscle fibre and force production characteristics during heavy resistance/power strength training in middle-aged and older men and women.
163	Häkkinen K et al.	Selective muscle hypertrophy, changes in EMG and force, and serum hormones during strength training in older women.
164	Hänninen T, Pirttilä T.	Varhaiset neuropsykologiset muutokset dementiassa. Kokemuksia Cerad-tehtäväsarjan käytöstä.
165	Hänninen T, Pulliainen V.	Neuropsykologinen seulonta.
166	Hänninen-Nousiainen P et al.	Suomalaisen kätilötyön historia - tuntemalla menneisyytemme osaamme rakentaa tulevaisuutta.
167	Ihalainen JA et al.	alpha2c-Adrenoceptors modulate the effect of methylphenidate on response rateand discrimination accuracy in an operant test.
168	Ikonen M.	Apoptosis-associated Changes in Neuronal Gene Expression. With Special Emphasis on the Insulin-like Growth Factor System.
169	Ikonen S, Tanila H.	Effects of metrifonate on the hippocampal theta rhythm of freely moving intact and MS-lesioned mice.
170	Ikäheimo K et al.	Adverse ocular effects of flecainide.
171	Ikäheimo R.	Aikuisten virtsatieinfektioiden diagnostiikka ja hoito.
172	Ikäheimo R.	Virtsatieinfektioiden uudet hoitosuositukset.
173	Immonen J et al.	Skin-prick test findings in students from moisture- and mould-damaged schools: A 3-year follow-up study.
174	Jakob SM.	Splanchnic Vasoregulation and Metabolism. New Insights into Physiology.
175	Jakob SM et al.	Splanchnic perfusion during hemodialysis: evidence for marginal tissue perfusion.
176	Jakob SM et al.	Effects of systemic arterial hypoperfusion on splanchnic hemodynamics and hepatic arterial buffer response in pigs.
177	Jakovljevic D et al.	Socioeconomic status and ischemic stroke: the FINMONICA stroke register.
178	Jakovljevic D et al.	Socioeconomic differences in the incidence, mortality and prognosis of intracerebral hemorrhage in Finnish adult population.
179	Jakovljevic D et al.	Socioeconomic inequalities in the incidence, mortality and prognosis of subarachnoid hemorrhage: the FINMONICA stroke register.
180	Jansen MCJF et al.	Cohort analysis of fruit and vegetable consumption and lung cancer mortality in european men.
181	Jantunen E.	Kantasolusiirtopotilaiden aspergillusinfektiot.
182	Jantunen E.	Pitkäkestoinen trombosytopenia.
183	Jantunen E et al.	Autologiset kantasolusiirrot myeloomapotilaiden hoidossa.
184	Jantunen E et al.	Keliakia ja lymfooma.
185	Jantunen E et al.	Autologiset kantasolusiirrot non-Hodgkin-lymfoomissa.
186	Jauhiainen K et al.	Kliininen kuormituskoe sepelvaltimotaudin diagnostiikassa.
187	Jensen KM-E et al.	Reconstructive urology in the Nordic countries.
188	Johansson R.	Syövän vai hoidon aiheuttamat oireet.
189	Jokinen C et al.	Microbial etiology of community-acquired pneunomia in the adult population of 4 municipalities in Eastern Finland.
190	Jokinen JJ et al.	Pitkäaikaisennuste ja elämänlaatu sepelvaltimoiden ohitusleikkauksen jälkeen.
191	Jokiniemi T, Ikäheimo R.	Etyleeniglykolimyrkytykset Pohjois-Savossa 1984-98.
192	Jolkkonen E et al.	Projections from the amygdalo-piriform transition area to the amygdaloid coplex: A PHA-L study in rat.
193	Jolkkonen E et al.	Interconnectivity between the amygdaloid complex and the amygdalostriatal transition area: a PHA-L study in rat.
194	Jolkkonen J et al., ed.	11th Nordic Meeting on Cerebrovascular Diseases and 2nd Biennial Symposium on Ischaemic Stroke.
195	Jormanainen V et al.	Lääkäreiden tupakoiville potilailleen suosittelemat tupakoinnin lopettamismenetelmät vuonna 1995.
196	Juntunen A et al.	A major role of viruses in convulsive status epilepticus in children: a prospective study of 22 children.
197	Jussila J et al.	Inflammatory responses in mice after intratracheal instillation of spores of streptomyces californicus isolated from indoor air of a molby building.
198	Jutila L et al.	Neurobiology of epileptogenesis in the temporal lobe.
199	Jutila L et al.	MR volumetry of the entorhinal, perirhinal, and temporopolar cortices in drug-refractory temporal lobe epilepsy.
200	Juva K et al.	Sex differences in cognitive performance among the very old - Mini-mental state examination in a population aged 85 years and over.
201	Jämsén T et al.	Results of infrainguinal bypass surgery: An analysis of 263 consecutive operations.
202	Järvinen R, Uusitupa M.	D-vitamiini ja eturauhassyöpä.
203	Jääskeläinen J et al.	Sexual function and fertility in adult females and males with congenital adrenal hyperplasia.
204	Kaipiainen-Seppänen O et al.	Regional differences in the incidence of rheumatoid arthritis in Finland in 1995.
205	Kaipiainen-Seppänen O, Hyvärinen L.	To the editor (Adverse reactions to rifabutin).
206	Kaipiainen-Seppänen O, Savolainen A.	Changes in the incidence of juvenile rheumatoid arthritis in Finland.
207	Kallinen J et al.	Antenatal gene tests in low-risk pregnancies: molecular screening for aspartylglucosaminuria (AGU) and infantile neuronal ceroid lipofuscinosis (INCL) in Finland.
208	Kallinen J et al.	Antenatal genetic screening for congenital nephrosis.
209	Kallinen J et al.	Wide scope prenatal diagnosis at Kuopio University Hospital 1997-1998: integration of gene tests and fetal karyotyping.
210	Kallio J et al.	Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans.
211	Kaminska R.	The Role of Mast Cell Proteinases in the Formation of Skin Blisters.
212	Kanerva J et al.	Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional study.
213	Kanerva J et al.	Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up.
214	Kanerva L et al.	A multicenter study of patch test reactions with dental screening series.
215	Kannisto S.	Adrenocortical Function, Bone Metabolism, and Growth in Asthmatic Children During the Initiation Phase of Inhaled Steroid Therapy.
216	Kannisto S et al.	Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression in asthmatic children treated with inhaled steroids.
217	Kanto-Ronkanen A.	Pieniä poimintoja asuntomessuilta Kajaanista.
218	Kanto-Ronkanen A.	Turvallisuutta kotona asumiseen.
219	Kanto-Ronkanen A.	Ympäristönhallintajärjestelmiä käytetään monipuolisesti.
220	Kareinen A et al.	Cardiovascular risk factors associated with insulin resistence cluster in families with early-onset coronary heart disease.
221	Karjalainen JM.	Transcription factors and other dysregulated proteins in melanoma prognosis.
222	Karkkainen MJ et al.	A model for gene therapy of human hereditary lymphedema.
223	Karonen J.	TT edelleen yleisin aivoiskemian kuvantamisessa.
224	Karonen J.	Diffusion and Perfusion Magnetic Resonance Imaging in Human Acute Ischemic Stroke.
225	Karonen JO et al.	Evolution of MR contrast enhancement patterns during the first week after acute ischemic stroke.
226	Karonen JO et al.	Diffusion and perfusion MR imaging in acute ischemic stroke: a comparison to SPECT.
227	Karpanen T et al.	Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.
228	Karvonen MK et al.	Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men.
229	Kaste M et al.	Aivoverenkiertohäiriöt.
230	Kataja V et al.	Kudoksensisäinen sädehoito paikallisen eturauhassyövän hoidossa.
231	Kaukanen E.	Keuhkoembolian hajottaminen katetrilla antaa sydämen toiminnalle lisäaikaa.
232	Kaukua J et al.	Clustering of cardiovascular risk factors in type 2 diabetes mellitus: prognostic significance and tracking.
233	Kauppinen J et al.	PCR-based typing of Mycobacterium avium isolates in an epidemic among farmed lesser white-fronted geese (Anser erythropus).
234	Kauppinen R et al.	Long-term economic evaluation of intensive patient education during the first treatment year in newly diagnosed adult asthma.
235	Kauppinen T et al.	Kiintymyssuhde vanhempiin ja psykosomaattinen oireilu nuoruusiässä.
236	Kauppinen T et al.	Quantitation of neuroreceptors: a need for better SPECT imaging.
237	Kavec M et al.	Use of spin echo T2 BOLD in assessment of cerebral misery perfusion at 1.5 T.
238	Kerokoski P et al.	Beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality.
239	Kerokoski P et al.	The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
240	Keskimäki M et al.	EPEC, EAEC and STEC in stool specimens: Prevalence and molecular epidemiology of isolates.
241	Kettunen J et al.	The fixation properties of carbon fiber-reinforced liquid crystalline polymer implant in bone: An experimental study in rabbits.
242	Kettunen MI et al.	Cerebral T1rho relaxation time increases immediately upon global ischemia in the rat independently of blood glucose and anoxic depolarization.
243	Kimbell-Dunn MR et al.	Work-related respiratory symptoms in New Zealand farmers.
244	Kivinen PK et al.	Release of soluble tryptase but only minor amounts of chymase activity from cutaneous mast cells.
245	Kivipelto M et al.	Midlife vascular risk factors and late-life mild cognitive impairment. A population-based study.
246	Kivipelto M et al.	Midlife vascular risk factors and Alzheimer´s disease in later life: longitudinal, population based study.
247	Knuuti J et al.	Myocardial fatty acid oxidation in patients with impaired glucose tolerance.
248	Koistinaho M et al.	Specific spatial learning deficits become severe with age in beta-amyloid precursor protein transgenic mice that harbor diffuse beta-amyloid deposits but do not form plaques.
249	Koistinen HA et al.	Dyslipidemia and a reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acid.
250	Koivisto T et al.	Gastric tonometry after subarachnoid hemorrhage.
251	Koivisto T, Vapalahti M.	Comment to (Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: A clinical, prospective, randomized, controlled study).
252	Koivula I.	Uudet antimikrobit antimikrobiresistenssiä vastaan.
253	Koivula IH.	Epidemiology of community-acquired pneumonia.
254	Koivumaa-Honkanen H et al.	Self-reported life satisfaction and recovery from depression in a 1-year prospective study.
255	Koivumaa-Honkanen H et al.	Life satisfaction and suicide: a 20-year follow-up study.
256	Koivunen RM et al.	Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes.
257	Kokki A et al.	Kun päiväkirurgia lisääntyy, kivunhoito jää kodin vastuulle.
258	Kokki H.	Lastenanestesiologia 2001.
259	Kokki H, Reinikainen M.	Levopuudutteet lasten puudutuksissa.
260	Kokki H et al.	Perioperative intravenous ketoprofen neither prolongs operation time nor delays discharge after adenoidectomy in children.
261	Kokki H et al.	Pharmacokinetics of ketoprofen following oral and intramuscular administration in young children.
262	Kolehmainen M et al.	Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity.
263	Konttinen YT et al.	Hyaluronan synthases, hyaluronan, and its CD44 receptor in tissue around loosened total hip prostheses.
264	Korhonen K et al.	Reasons for and costs of hospitalization for pediatric asthma: A prospective 1-year follow-up in a population-based setting.
265	Korhonen S et al.	Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: A controlled, population-based study.
266	Korhonen V et al.	Effect of major depression on the self-image of adolescent boys and girls.
267	Korhonen V-P et al.	Spermine deficiency resulting from targeted disruption of the spermine synthase gene in embryonic stem cells leads to enhanced sensitivity to antiproliferative drugs.
268	Korkeila J et al.	Psykiatrian alan lääkärien työuupumus.
269	Korppi M, Heiskanen-Kosma T.	Bacterial community-acquired pneumonia in children: changes in causative agents.
270	Korppi M, Remes S.	Serum procalcitonin in pneumococcal pneumonia in children.
271	Koskela H.	Veripaikka ilmarinnan hoidossa.
272	Koskinen O et al.	Increased risk of violent recidivism among adult males is related to single-parent family during childhood: the Northern Finland 1966 Birth Cohort Study.
273	Koskinen T.	Laitosvanhusten mielenterveyshäiriöiden tunnistaminen ja hoito.
274	Koskinen T.	Voidaanko lääkehoidon komplianssia parantaa?
275	Koskinen T.	Näiline Dementsus. (pseudodementsus).
276	Koskiniemi M et al.	Infections of the central nervous system of suspected viral origin: a collaborative study from Finland.
277	Koukkunen H et al.	C-reactive proteins, fibrinogen, interleukin-6 and tumour necrosis factor-alfa in the prognostic classification of unstable angina pectoris.
278	Koukkunen H et al.	Ruling out myocardial infarction with Troponin T and creatine kinase MB massa: diagnostic and prognostic aspects.
279	Koukkunen H et al.	Differences in the diagnosis of myocardial infarction by troponin T compared with clinical and epidemiologic criteria.
280	Kouri JP, Airaksinen O.	Kivun käsitteet selviksi.
281	Kraszpulski M et al.	The load and distribution of beta-amyloid in brain tissue of patients with Alzheimer´s disease.
282	Kromhout D et al.	Physical activity and dietary fiber determine population body fat levels: the Seven Countries Study.
283	Kröger H.	Osteoporoottisten murtumien sekundaaripreventio ortopedin kannalta.
284	Krüüner A et al.	Tuberculosis as an occupational hazard for health care workers in Estonia.
285	Kubová H et al.	Status epilepticus causes necrotic damage in the mediodorsal nucleus of the thalamus in immature rats.
286	Kuhmonen J et al.	Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat.
287	Kuikka JT.	Modeling tissues contrast agent concentration: A solution to the tissue homogeneity model using a simulated arterial input function.
288	Kuikka JT et al.	Imaging of the endothelial dysfunction in coronary atherosclerosis.
289	Kuikka JT et al.	Effects of ageing on serotonin transporters in healthy females.
290	Kuikka JT et al.	Reduced serotonin transporter binding in binge eating women.
291	Kumpulainen K et al.	Psychiatric disorders and the use of mental health services among children involved in bullying.
292	Kumpulainen K, Säiniö M.	Lasten psyykkiset häiriöt, oppiminen ja koulunkäynti.
293	Kurkinen K et al.	Isoform-specific membrane translocation of protein kinase C after ischemic preconditioning.
294	Kurkinen K et al.	Preconditioning with spreading depression activates specifically protein kinase Cdelta.
295	Kurl S et al.	Systolic blood pressure response to exercise stress test and risk of stroke.
296	Kuusisto E et al.	Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies.
297	Kuusisto E et al.	Ubiquitin-binding protein p62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells.
298	Kuusisto J et al.	Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men.
299	Kvist T et al.	Ihmisläheinen hoito-potilaskyselyn tulokset Kuopion yliopistollisessa sairaalassa, Iisalmen ja Varkauden aluesairaaloissa vuonna 2000.
300	Kylmä J et al.	Hope, despair and hopelessness in living with HIV/AIDS: a grounded theory study.
301	Kylmä J et al.	Dynamically fluctuating hope, despair and hopelessness along the HIV/AIDS continuum as described by caregivers in voluntary organizations in Finland.
302	Kylmä J et al.	Voluntary caregivers' observations on the dynamics of hope across the continuum of HIV/AIDS: A focus group study.
303	Kylmä J et al.	Dynamics of hope in living with HIV: professional caregivers' observations.
304	Kyrölä K et al.	Preoperatiivinen MRI-artrografia rotator cuff-kirurgiassa.
305	Kähkönen S et al.	Ethanol modulates cortical activity: direct evidence with combined TMS and EEG.
306	Kälviäinen R.	Epilepsia ja ikääntyminen. Pääkirjoitus.
307	Kälviäinen R.	Monotherapy trial design: conversion versus de novo.
308	Kälviäinen R.	Long-term safety of tiagabine.
309	Kälviäinen R.	Ikääntyneiden epilepsia yleistyy.
310	Kälviäinen R.	Epilepsialääkkeet säilytettävä edelleen erityiskorvattavina.
311	Kälviäinen R.	Terveiset Buenos Airesista.
312	Kälviäinen R.	Kiitos luottamuksestanne.
313	Kälviäinen R, Keränen T.	Epilepsia.
314	Kälviäinen R, Nousiainen I.	Visual field defects with vigabatrin. Epidemiology and therapeutic implications .
315	Kälviäinen R, Äikiä M.	Kognitiiviset häiriöt neurologisissa sairauksissa. Epilepsia.
316	Laakko K, Vänskä K.	Kun yhteistyö toimii, laihdutusleikkaus sujuu.
317	Laakso M.	Linkkejä muistihäiriö- ja dementiasivuille.
318	Laakso M.	Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention.
319	Laakso M.	Insulin resistance and its impact on the approach to therapy of type 2 diabetes.
320	Laakso M.	Diabetes and cardiovascular disease.
321	Laakso M.	Diabetic macroangiopathy.
322	Laakso MP et al.	A morphometric MRI study of the hippocampus in first-episode, neuroleptic-naive schizophrenia.
323	Laakso MP et al.	Psychopathy and the posterior hippocampus.
324	Laasonen-Balk T et al.	Cluster C personality disorder has no independent effect on stratial dopamine transporter densities in major depression.
325	Lahtinen P et al.	Kivunhoito sydänleikkauksen jälkeen.
326	Laine TPJ et al.	The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics.
327	Laine TPJ et al.	Dopamine transporter density and novelty seeking among alcoholics.
328	Laitinen JT et al.	[35S]GTPgammaS autoradiography reveals a wide distribution of Gi/o-linked ADP receptors in the nervous system: close similarities with theplatelet P2Y ADP receptor.
329	Laitinen KSM et al.	Brain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulation.
330	Laivoranta-Nyman S et al.	Differences between female and male patients with familial rheumatoid arthritis.
331	Lakka TA et al.	Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men.
332	Lakka TA et al.	Cardiorespiratory fitness and the progression of carotid atherosclerosis in middle-aged men.
333	Lamberg M.	Infektio suussa - yleisterveys vaarassa.
334	Lamusuo S et al.	[18F] FDG-PET reveals temporal hypometabolism in patients with temporal lobe epilepsy even when quantitative MRI and histopathological analysis show only mild hippocampal damage.
335	Lanrson A et al.	Stora skillnader i användingen av laboratorieanalyser mellan några utvalda laboratorier i Norden.
336	Laukkanen E et al.	The stability and correlates of a negative coping self among adolescents.
337	Laukkanen E et al.	A pessimistic attitude towards the future and low psychosocial functioning predict psychiatric diagnosis among treatment-seeking adolescents.
338	Laukkanen E et al.	The effect of congenital handicap on personality development in adolescence.
339	Laukkanen E et al.	Koulun yhteisöllisyys - väline vaikuttaa nuorten terveeseen kasvuun.
340	Laukkanen ER et al.	Heavy drinking is associated with more severe psychosocial dysfunction among girls than boys in Finland.
341	Laukkanen JA et al.	Exercise-induced silent myocardial ischemia and coronary morbidity and mortality in middle-aged men.
342	Laukkanen JA et al.	Cardiovascular fitness as a predictor of mortality in men.
343	Laukkanen MO et al.	EC-SOD gene therapy reduces paracetamol-induced liver damage in mice.
344	Laukkanen MO et al.	Gene transfer of extracellular superoxide dismutase to atherosclerotic mice.
345	Laurikkala J et al.	Analysis of the imputed female urinary incontinence data for the evaluation of expert system parameters.
346	Lauritsalo L, Mustonen P.	Rintarekonstruktio proteesilla kohentaa itsetuntoa ja elämänkalaatua.
347	Lehtonen J.	Psykoanalyysin tulevaisuudesta.
348	Lehtonen J.	Psykoanalyysi 2000-luvulle.
349	Lehtonen J.	Luottamus terveydenhuollossa.
350	Lehtovirta M.	Perinnöllisyys ja geenitestit.
351	Leino K et al.	Validation of a new respiratory inductive plethysmograph.
352	Leinonen V et al.	Disc herniation-related back pain impairs feed-forward control of paraspinal muscles.
353	Leppänen PM et al.	Optimized in situ PCR method for the detection of gene transfer vector in histological sections.
354	Leuppi JD et al.	Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids.
355	Leuppi JD et al.	Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma.
356	Liippo J et al.	Both normal and leukemic B lymphocytes express multiple isoforms of the human Aiolos gene.
357	Lindgren A et al.	Cancer incidence in hypertensive patients in North Karelia, Finland.
358	Lindgren BF et al.	Nitrogen sparing effect of structured triglycerides containing both medium-and long-chain fatty acids in critically ill patients; a double blind randomized controlled trial.
359	Lindi V et al.	Effect of the Pro12Ala polymorphism of the PPAR-gamma2 gene on lon-term weight change in Finnish non-diabetic subjects.
360	Lindén A-M et al.	Increased expression of neuronal Src and tyrosine phosphorylation of NMDA receptors in rat brain after systemic treatment with MK-801.
361	Lindén A-M et al.	Uncompetitive antagonists of the N-methyl-D-aspartate (NMDA) receptors alter the mRNA expression of proteins associated with the NMDA receptor complex.
362	Lintula H et al.	Single-blind randomized clinical trial of laparoscopic versus open appendicectomy in children.
363	Lipponen P et al.	High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer.
364	Liu J et al.	Gonadotrophins inhibit and activin induces expression of inhibin /activin beta-B subunit mRNA in cultured human granulosa-luteal cells.
365	Loimas S et al.	Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy.
366	Lozeva V et al.	Changes in brain histamine H1 receptors in chronic hepatic encephalopathy.
367	Lozeva V et al.	Increased density of brain histamine H1 receptors in rats with portacaval anastomosis and in cirrhotic patients with chronic hepatic encephalopathy.
368	Luiro K et al.	CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease.
369	Lumiaho A et al.	Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1.
370	Lundell L et al.	Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease.
371	Lundin J et al.	Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: Results from a nationwide study.
372	Lunt M et al.	A statistical method to minimize magnification errors in serial vertebral radiographs.
373	Luostarinen A, Klemola L.	Kokemuksia photodynaamisesta terapiasta.
374	Luostarinen A, Klemola L.	Fotodynaaminen hoito.
375	Luostarinen L et al.	Association between coeliac disease, epilepsy and brain atrophy.
376	Luostarinen LK et al.	Coeliac disease in patients with cerebellar ataxia of unknown origin.
377	Lyyra-Laitinen T et al.	Development of arthroscopic indentation technique for the diagnosis of cartilage degeneration.
378	Lyytikäinen H.	Potilaan, omaisten ja henkilökunnan yhteistyö tehohoidon rajaamisessa.
379	Lyytikäinen H et al.	Tehohoidon rajaaminen - käsiteanalyysi Walker & Avantin menetelmällä.
380	Länsimies E.	Clinical Physiology 1998-2001.
381	Lång M et al.	Outcome and resource utilization in gastroenterological surgery.
382	Makkonen N.	Recovery, Recurrence and Familial Aspects in Preeclampsia-Counselling Patients and Their Families.
383	Makkonen N et al.	Apolipoprotein E alleles in women with pre-eclampsia.
384	Manninen H.	Toimenpideradiologia.
385	Manninen HI.	Intravascular ultrasound imaging in the quantitation of atherosclerosis in vivo.
386	Manninen HI, Kaukanen ET.	Drs Manninen and Kaukanen respond (to Branchial arterial access).
387	Manninen HI et al.	Brachial arterial access: Endovascular treatment of failing Brescia-Cimino hemodialysis fistulas-initial success and long-term results.
388	Manninen P et al.	Physical exercise and risk of severe knee osteoarthritis requiring arthroplasty.
389	Markkanen A et al.	Effects of 50 Hz magnetic field on cell cycle kinetics and the colony forming ability of budding yeast exposed to ultraviolet radiation.
390	Marvanová M et al.	The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain.
391	Mattila MAK.	Moderni lääketiede. Ruoka - liikunta - hyvinvointi.
392	Mattila MAK.	Ydinlämpötilan lasku traumapotilailla.
393	Mattila MAK.	12. Maailman katastrofilääketieteen kongressi Lyonissa Ranskassa 2001.
394	Mehta PD et al.	Amyloid beeta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease.
395	Mehto P.	Kuopion yliopistollisen sairaalan toimintolaskentapilottiprojektin loppuraportti.
396	Mehto P et al.	Kammoksuttu kuolema.
397	Menotti A et al.	The association of silent electrocardiographic findings with coronary deaths among elderly men in three European countries. The FINE study.
398	Menotti A et al.	Cardiovascular risk factors and 10-year all-cause mortality in elderly European male populations.
399	Mervaala E et al.	SPECT and neuropsychological performance in severe depression treated with ECT.
400	Meurling CJ et al.	Diurnal variations of the dominant cycle length of chronic atrial fibrillation.
401	Meurman JH, Koivula I.	Vaaralliset infektiotaudit ja antibioottiresistenssi suun terveydenhuollon kannalta.
402	Miettinen H.	Lonkan ja polven tekonivelleikkaus 2000-luvulla.
403	Miettinen H, Kettunen J.	Lonkan ja polven tekonivelleikkaus vuosituhannen vaihteessa.
404	Miettinen HE et al.	Cell cycle regulators (p21, p53, pRb) in oligodendrocytic tumors: a study by novel tumor microarray technique.
405	Miettinen VM et al.	Release of fluoride from glass fiber-reinforced composite with multiphase polymer matrix.
406	Mikkonen M et al.	Hippocampal plasticity in Alzheimer´s disease.
407	Mitrunen K et al.	Polymorphic catechol-O-methyltransferase gene and breast cancer risik.
408	Mitrunen K et al.	Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.
409	Mitrunen K et al.	Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk.
410	Moilanen JS et al.	Complex segregation analysis of Parkinson´s disease in the finnish population.
411	Molin D et al.	Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.
412	Mrózek K et al.	Clinical importance of cytogenetics in acute myeloid leukaemia.
413	Mussalo H et al.	Heart rate variability and its determinants in patients with severe or mild essential hypertension.
414	Mustonen P, Vanninen E.	Vartijaimusolmukkeet rintasyövässä.
415	Mykkänen M, Virranta S.	Vertaisarviointimenetelmä sairaanhoitajien toiminnan kehittämisessä tehohoidon osastolla-havainnointitutkimus.
416	Myllykangas L et al.	Association of lipoprotein lipase Ser447Ter polymorhphism with brain infarction: a population-based neuropathological study.
417	Myllykangas-Luosujärvi R et al.	Reply (to Amyloidosis in a series of 964 Portuguese rheumatoid arthritis patients).
418	Myllykangas-Luosujärvi R et al.	Two clusters of different rheumatic diseases in moisture damaged buildings.
419	Myrvold HE et al.	The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery.
420	Mäkelä EA.	Luutuumorit.
421	Mäkelä HI et al.	Proton exchange as a relaxation mechanism for T1 in the rotating frame in native and immobilized protein solutions.
422	Mäkinen J et al.	Morbidity of 10 110 hysterectomies by type of approach.
423	Mäkinen T et al.	Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.
424	Mäntyjärvi M.	Normal test scores in the Farnsworth-Munsell 100 hue test.
425	Mäntyjärvi M, Laitinen T.	Normal values for the Pelli-Robson contrast sensitivity test.
426	Mäntyjärvi M et al.	Clinical features and follow-up study in a family with X-linked progressive cone-rod dystrophy.
427	Mäntyjärvi M et al.	Screening color vision in preschool-aged children.
428	Mäntyselkä P et al.	Pain as a reason to visit the doctor: a study in Finnish primary health care.
429	Naaranlahti T, Saano S.	Rabdomyolyysi lääkeaineinteraktion seurauksena.
430	Naaranlahti T, Saano S.	Lääkkeen aiheuttama haimatulehdus.
431	Neva MH et al.	Mortality associated with cervical spine disorders: a population-based study of 1666 patients with rheumatoid arthritis who died in Finland in 1989.
432	Niemelä M, Peuhkurinen K.	Tieteelliseen näyttöön perustuva sydämen vajaatoiminnan lääkehoito.
433	Niemeläinen M et al.	Kuopion yliopistollisen sairaalan luupankki.
434	Niemimaa M et al.	Äitien veriseulonta keskiraskauden aikana paljastaa myös sikiön 18-trisomian.
435	Niemimaa M et al.	First-trimester screening for Down`s syndrome in vitro fertilization pregnancies.
436	Niemimaa M et al.	Evaluation of first trimester maternal serum and ultrasound screening for Down*s syndrome in Eastern and Northern Finland.
437	Nieminen MT et al.	T2 Relaxation reveals spatial collagen architecture in articular cartilage: a comparative quantitative MRI and polarized light microscopic study.
438	Niskanen L et al.	Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen.
439	Niskanen M et al.	Laadunvalvontaa anestesiaosastolla: kahden menetelmän vertailu komplikaatioiden kirjaamisessa.
440	Niskanen MM, Takala JA.	Use of resources and postoperative outcome.
441	Nissinen J et al.	Is mossy fiber sprouting present at the time of the first spontaneous seizures in rat experimental temporal lobe epilepsy?
442	Nissinen M et al.	Smith-Lemli-Opitzin oireyhtymän diaknostiikka kaasukromatografian avulla.
443	Nitschke L et al.	Deletion of the DQ52 element within the Ig heavy chain locus leads to a selective reduction in VDJ recombination and altered D gene usage.
444	Nobuhara K et al.	SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNP.
445	Nousiainen I et al.	No reversion in vigabatrin-associated visual field defects.
446	Nousiainen T.	Karvasoluleukemian diagnostiikka ja nykyhoito.
447	Nousiainen T et al.	Comparison of echocardiography and radionuclide ventriculography in the follow-up of left ventricular systolic function in adult lymphoma patients during doxorubicin therapy.
448	Nousiainen T et al.	Anthracycline-induced cardiomyopathy: long-term effects on myocardial cell integrity, cardiac adrenergic innervation and fatty acid uptake.
449	Nousiainen T et al.	Neuroendocrine changes during the evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients.
450	Nuikka M-L et al.	The nurse's workload in care situations.
451	Närvänen O et al.	Evaluation and characterization of EIA measuring autoantibodies against oxidized LDL.
452	Närvänen O et al.	Technical and clinical aspects about autoantibody assays for oxidized low density lipoprotein.
453	Ojala M et al.	Epilepsia ja ajokyvyn arviointi - suomalainen menettelyohje.
454	Ojala M, Kälviäinen R.	Insurability of patients with epilepsy: perspectives of physicians and insurance companies.
455	Ollikainen J et al.	Chronic lung disease of the newborn is not associated with Ureaplasma urealyticum.
456	Paassilta P et al.	Identification of a novel common genetic risk factor for lumbar disk disease.
457	Paavola P et al.	Genetic analysis in Finnish families with inflammatory bowel disease supports linkage to chromosome 3p21.
458	Paloneva J et al.	CNS manifestations of Nasu-Hakola disease. A frontal dementia with bone cysts.
459	Papp A et al.	Palovammat KYS:n palovammakeskuksessa 1994-2000.
460	Papp A et al.	Local unilateral gastrocnemius flap in complicated total knee arthrosplasty.
461	Parkkinen L et al.	alpha-Synuclein pathology is highly dependent on the case selection.
462	Partanen K et al.	Aivojen kuvantaminen.
463	Pasonen-Seppänen S et al.	Formation of permeability barrier in epidermal organotypic culture for studies on drug transport.
464	Pasonen-Seppänen S et al.	Vitamin C enhances differentation of a continuous keratinocyte cell line (REK) into epidermis with normal stratum corneum ultrastructure and functional permeability barrier.
465	Pelkonen M et al.	Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study.
466	Penttilä HJ et al.	Myocardial preservation during coronary surgery with and without cardiopulmonary bypass.
467	Penttilä I et al.	Analyyttiset näkökohdat uuden sydäninfarktin kansainvälisen diagnostiikkasuosituksen mukaisesti toimittaessa.
468	Pesonen TM et al.	Male suicide mortality in eastern Finland - urban-rural changes during a 10-year period between 1988 and1997.
469	Pienimäki J-P et al.	Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan.
470	Pietilä A-M, Vehviläinen-Julkunen K.	Preventiivisen hoitotieteen tutkimuksen ja koulutuksen lähtökohtia.
471	Pietilä A-M, Vehviläinen-Julkunen K.	Preventiivistä perhehoitotyötä kuvaavien tutkimusten tarkoitus ja tutkimustehtävät.
472	Pietilä A-M, Vehviläinen-Julkunen K.	Tutkimusten aineistot ja menetelmät.
473	Pietilä A-M et al.	Preventiivisen perhehoitotyön kehittäminen.
474	Pietilä A-M et al., toim.	Preventiivinen perhehoitotyö. Terveyttä edistävien työmenetelmien arviointia Lapsiperhe-projektissa.
475	Pietilä A-M et al.	Perhehoitotyö Lapsiperhe-projektissa: haastattelututkimus lapsiperheiden saamasta varhaisesta tuesta.
476	Pietilä M et al.	Relation of skin polyamines to the hairless phenotype in transgenic mice overexpressing spermidine/spermine N1-acetyltransferase.
477	Pietinen P et al.	Serum enterolactone and risk of breast cancer: A case-control study in Eastern Finland.
478	Pihlajamäki J et al.	A major gene effect on fasting insulin and insulin sensitivity in familial combined hyperlipidemia.
479	Pihlajamäki J et al.	The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance.
480	Pihlajamäki M et al.	Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
481	Pikkarainen M, Pitkanen A.	Projections from the lateral, basal and accessory basal nuclei of the amygdala to the perirhinal and postrhinal cortices in rat.
482	Pirinen E et al.	Mahapantaleikkaus lihavuuden kirurgisena hoitona.
483	Pirinen R et al.	Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarsinoma.
484	Pirinen RT et al.	Reduced expression of alfa-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.
485	Pirskanen M et al.	An association between a subset of Finnish late-onset Alzheimer´s disease and alpha2-macroglobulin.
486	Pirttilä T, ed.	The Second Kuopio Alzheimer Symposium. Kuopio Music Centre, Kuopio, Finland March 13-15, 2001. Program and abstracts.
487	Pirttilä T.	Kolinerginen lääkehoito Alzheimerin taudissa - osa hyvää hoitoa.
488	Pirttilä T.	Kliininen tutkimus.
489	Pirttilä T.	Laboratoriotutkimukset.
490	Pirttilä T.	Biologiset merkkiaineet.
491	Pirttilä T.	Targeted drug treatment for Alzheimer´s disease.
492	Pirttilä T, Erkinjuntti T.	Alzheimerin taudin kliininen kuva ja diagnoosi.
493	Pirttilä T, Oksi J.	Tarvitaanko selkäydinnestetutkimuksia 2000-luvulla?
494	Pirttilä T-RM et al.	Ex vivo MR microimaging of neuronal damage after kainate-induced status epilepticus in rat: correlation with quantitative histology.
495	Polvikoski T et al.	Prevalence of Alzheimer's disease in very elderly people. A prospective neutopathological study.
496	Poutanen T et al.	Transthoracic three-dimensional echocardiography is as good as magnetic resonance imaging in measuring dynamic changes in left ventricular volyme during the heart cycle in children.
497	Pukander J et al.	Endoscopic laser surgery for laryngeal cancer.
498	Pukkila MJ et al.	Nuclear beta catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma.
499	Pulkkanen K.	Gene Therapy for Human Renal Cell Carcinoma in an Orthotopic Nude Mouse Model.
500	Pulkkanen KJ et al.	HSV-tk gene therapy for human renal cell carcinoma in nude mice.
501	Puntila E et al.	Leisure-time physical activity and rate of bone loss among peri- and postmenopausal women: a longitudinal study.
502	Purhonen M et al.	Effects of maternity on auditory event-related potentials to human sound.
503	Purhonen M et al.	Dynamic behavior of the auditory N100 elicited by a baby`s cry.
504	Purokivi MK et al.	Changes in pro-inflammatory cytokines in association with exposure to moisture-damaged building microbes.
505	Puurunen K.	The Effects of Pharmacotherapy and Training on Functional Recovery after Global and Focal Cerebral Ischemia in Rats.
506	Puurunen K et al.	An alfa2-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats.
507	Puurunen K et al.	Selegiline combined with enriched-environment housing attenuates spatial learning deficits following focal cerebral ischemia in rats.
508	Puurunen K et al.	Enriched-environment housing increases neuronal Fos-staining in the dentate gyrus after a water maze spatial learning task.
509	Puustjärvi TJ, Teräsvirta ME.	Retinal fixation of traumatic retinal detachment with metallic tacks.
510	Pyörälä K, Klaukka T.	Sepelvaltimotauti-, diabetes- ja verenpainepotilaiden lipidilääkkeiden käyttö Suomessa vuosina 1996-99.
511	Pyörälä K et al.	Toteutuvatko sepelvaltimotaudin sekundaaripreventiota koskevat suositukset?
512	Pääkkönen AK, Morgan MJ.	Linear mechanisms can produce motion sharpening.
513	Pölkki T et al.	Nonpharmacological methods in relieving children's postoperative pain: a survey on hospital nurses in Finland.
514	Raamat R et al.	Continuous mean arterial pressure measurement in the fingers: the influence of local arm cooling.
515	Rahiala E, Tikanoja T.	Suspicion of aortic coarctation in an outpatient clinic: How should blood pressure measurements be performed?
516	Rahkonen T et al.	Delirium in the non-demented oldest old in the general population: risk factors and prognosis.
517	Rahkonen T et al.	Systematic intervention for supporting community care of elderly people after a delirium episode.
518	Raitanen M-P et al.	Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
519	Raitanen MP et al.	Human complement factor H related protein test for monitoring bladder cancer.
520	Randell KM et al.	Hormone replacement therapy and risk of falling in early postmenopausal women-a population-based stydy.
521	Rankinen T et al.	The human gene map for performance and health-related fitness phenotypes.
522	Raunio P et al.	Preliminary description of antigenic components characteristic of Stachybotrys chartarum.
523	Rauramaa R, Lakka TA.	Liikuntaa sepelvaltimotaudin ehkäisyyn ja hoitoon.
524	Rauramaa R et al.	Dose-response and coagulation and hemostatic factors.
525	Rautiainen J et al.	Two new variants of the lipocalin allergen Bos d 2.
526	Rautio S.	Leikkaussalin valaistus - tilan vai tehtävien ehdoilla?
527	Reijonen T et al.	Pikkulasten astma.
528	Repo-Tiihonen E et al.	Mortality of antisocial male criminals.
529	Riikonen R.	Neurotrophic factors in the pathogenesis of Rett syndrome.
530	Riikonen R.	Epidemiological data of West syndrome in Finland.
531	Riikonen R.	ACTH therapy of West syndrome: Finnish views.
532	Riikonen R.	The PEHO syndrome.
533	Riikonen R.	Long-term outcome of patients with West syndrome.
534	Rissanen P et al.	Weight change and blood coagulability and fibrinolysis in healthy obese women.
535	Rissanen S et al.	Yli 75-vuotiaiden vanhusten yksityisten ja julkisten lääkäri- ja kotipalvelujen käyttö.
536	Rissanen TH et al.	Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study.
537	Rissanen TT et al.	Gene therapy for therapeutic angiogenesis in critically inschaemic lower limb - on the way to the clinic.
538	Ristikankare M et al.	The effects of gender and age on the colonoscopic examination.
539	Riukka L et al.	Lääkäreiden ja sairaanhoitajien odotukset sairaala-apteekkien lääkeinformaatiopalvelulta.
540	Romppanen EL.	Oligonucleotide ligation assay: application to molecular diagnosis os inherited disorders.
541	Ronkainen A et al.	Evidence for excess long-term mortality after treated subarachnoid hemorrhage.
542	Ronkainen S, Syrjänen M.	Ammatillisen osaamisen kehittäminen.
543	Roponen M et al.	Inflammatory mediators in nasal lavage, induced sputum and serum of employees with rheumatic and respiratory disorders.
544	Roponen M et al.	Inflammatory mediators in nasal lavage, induced sputum and serum of employees with rheumatic and respiratory disorders.
545	Ropponen KM et al.	Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation.
546	Roschier M et al.	Insulin-like growth factor binding protein 5 and type- 1 insulin-like growth factor receptor are differentially regulated during apoptosis in cerebellar granule cells.
547	Rouvinen J et al.	Search for the determinants of allergenicity in proteins of the lipocalin family.
548	Ruoppi P et al.	Paranasal sinus mucormycosis: a report of two cases.
549	Ruoppi P et al.	In vitro and in vivo responses to the recombinant bovine dander allergen Bos d 2 and its fragments.
550	Ruponen M et al.	Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes.
551	Rutanen J et al.	Clinical applications of vascular gene therapy.
552	Ruutiainen J, Sivenius J.	Etenevät neurologiset sairaudet.
553	Ryynänen O-P et al.	General practitioners' willingness to request plain lumbar spine radiographic examinations.
554	Räihä I et al.	Poor performance in the Mini-Mental State Examination due to causes other than dementia.
555	Räsänen JV et al.	Health-related quality of life before and after gastrointestinal surgery.
556	Saano S, Naaranlahti T.	Serotoniinioireyhtymä.
557	Saarelainen T et al.	trkB-receptor activation contributes to the kainate-induced increase in BDNF mRNA synthesis.
558	Saarenmaa I et al.	The visibility of cancer on previous mammograms in retrospective review.
559	Saarenmaa I et al.	Validity of radiological examinations of patients with breast cancer different age groups in a population based study.
560	Saarenmaa I et al.	The effect of age and density of the breast on the sensitivity of breast cancer diagnostic by mammography and ultrasonography.
561	Saari KM et al.	Silmän tutkiminen.
562	Saarikoski S.	Raskauden keston häiriöt.
563	Saarinen J.	Mast Cell Mediators in Immediate Allergic Wheal Reaction.
564	Saarinen JV et al.	Modulation of the immediate allergic wheal reaction in the skin by drugs inhibiting the effects on leukotriene C4 and prostaglandin D2.
565	Saarinen JV et al.	Interleukin-4-posituve mast cells are highly associated with the extent of immediate allergic wheal reaction in the skin.
566	Saarinen JV et al.	The release of histamine is associated with the inactivation of mast cell chymase during immediate allergic wheal reaction in the skin.
567	Saarinen P.	Itsetuhoisuus skitsofreniassa.
568	Saarinen P et al.	Läheisen itsemurhaan sopeutuminen.
569	Sahlman J et al.	Premature vertebral endplate ossification and mild disc degeneration in mice after inactivation of one allele belonging to the Col2a1 gene for Type II collagen.
570	Salmenkivi K et al.	Inhibin/activin beta-B-subunit expression in pheochromocytomas favors benign diagnosis.
571	Salmenperä T.	Damage in the Hippocampus, Amygdala, Entorhinal and Perirhinal cortex of Adults With Partial Epilepsy.
572	Salmenperä T et al.	Hippocampal and amygdaloid damage in partial epilepsy A cross-sectional MRI study of 241 patients.
573	Salmi L, Niinimäki J.	Selviytyykö lääkäri verkossa?
574	Salmén T et al.	Estrogeenireseptori alfa-geenin polymorfia vaikuttaa hormonikorvaushoidon luustolle antamaan suojaan.
575	Salomaa V et al.	Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events: the FINMONICA MI Register Studt.
576	Salonen A et al.	I.V. ketoprofen for analgesia after tonsillectomy: comparison of pre- and post-operative administration.
577	Sarkkinen R et al.	Keski-Suomen keskussairaalassa vuosina 1983-1990 ja 1991-1998 hoidetut myeloomapotilaat.
578	Savolainen S et al.	Auditory event-related potentials differentiate patients with normal pressure hydocephalus and patients with concomitant Alzheimer´s disease verified by brain biopsy.
579	Savolainen S, Vapalahti M.	Hydrokefaalinen dementia.
580	Schmidt D et al.	Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view.
581	Schmidt-Trucksäss A et al.	Computerized analysing system using the active contour in ultrasound measurement of carotid artery intima-media thickness.
582	Schreiner PJ et al.	Gender differences in recurrent coronary events: The FINMONICA MI register.
583	Second SYMPHONY Investigators.	Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes.
584	Sentman M-L et al.	Extracellular superoxide dismutase deficiency and atherosclerosis in mice.
585	Serlo W et al.	Use of self-reinforced polyactide osteosynthesis devices in craniofacial surgery: A long-term follow-up study.
586	Setälä L et al.	Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer.
587	Siloaho M et al.	A pilot experiment of joint assessments by accreditation bobies in clinical laboratories.
588	Siloaho M et al.	Key elements of the implementation of a quality system in three Finnish clinical laboratories.
589	Silver HM et al.	Comparison of vagal baroreflex function in nonpregnant women and in women with normal pregnancy, preeclampsia, or gestational hypertension.
590	Simula S.	Cardiac Adrenergic Innervation in Coronary Artery Disease - Studies with I123-metaiodobenzylguanidine.
591	Sinkkonen ST et al.	Characterization of gamma-aminobutyrate type A receptors with atypical coupling between agonist and convulsant binding sites in discrete brain regions.
592	Sivenius J.	Ikääntyneen aivohalvauspotilaan hoidon ja kuntoutuksen periaatteita.
593	Sivenius J.	Aivohalvauspotilaan kuntoutuksen vaikuttavuus ja käytännön periaatteet.
594	Sivenius J et al.	Selegiline treatment facilitates recovery after stroke.
595	Sivenius J, Tarkka IM.	Aivovauriot.
596	Sivenius K et al.	Effect of a three-amino acid deletion in the alfa2B-adrenergic receptor gene on long-term body weight change in Finnish non-diabetic and type 2 diabetic subjects.
597	Slotte V et al.	Information technology in medical education: a nationwide project on the opportunities of the new technology.
598	Soimakallio S.	Katsaus KYS:n sairaanhoitopiirien tilanteeseen ja kehitysnäkymiin.
599	Soimakallio S, Liukko M.	Säteilyn lääketieteellisen käytön kliininen auditointi.
600	Soimakallio S, Pamilo M.	Kuvantamistoiminnan nykytila Suomessa.
601	Soimakallio S, Pyhtinen J.	Röntgenlähete juridisena asiakirjana.
602	Soininen H.	Muistihäiriöiden ja dementian ennaltaehkäisy.
603	Soininen H, Hänninen T.	Muistihäiriöiden oirediagnostiikka.
604	Soininen H, Partanen J.	Kliinis-neurofysiologiset tutkimukset.
605	Sorri I.	Effects of Antiepileptic Drugs on Visual Function, with Special Reference to Vigabatrin.
606	Sudah M et al.	MR urography in evalution of acute flank pain: T2-weighted sequences and gadolinium-enhanced three-dimensional FLASH compared with urography.
607	Sulkava R.	Dementiapotilaan käytösoireet.
608	Sulkava R.	Neurogeriatria.
609	Suomalainen S et al.	Pulmonary infection caused by an unusual, slowly growing nontuberculous Mycobacterium.
610	Suomen muistitutkimusyksiköiden asiantuntijatyöryhmä.	Dementiapotilaiden käytösoireet.
611	Suomen muistitutkimusyksiköiden asiantuntijatyöryhmä:.	Dementiapotilaiden käytösoireiden lääkkeetön hoito.
612	Suomen muistitutkimusyksiköiden asiantuntijatyöryhmä:.	Dementiaan liittyvien käytösoireiden lääkehoito.
613	Suominen MM et al.	Effects of intra-articular injections of bufexamac suspension in healthy horses.
614	Suppola S et al.	Concurrent overexpression of ornithine decarboxylase and spermidine/spermine N1-acetyltransferase further accelerates the catabolism of hepatic polyamines in transgenic mice.
615	Sutula TP, Pitkänen A.	More evidence for seizure-induced neuron loss: is hippocampal sclerosis both cause and effect of epilepsy?
616	Säilä HM et al.	Juvenile idiopathic arthritis in multicase families.
617	Tacke U.	Tietoa huumeista ja huumeiden käyttäjistä.
618	Tacke U, Tuomisto J.	Riippuvuus ja väärinkäyttö.
619	Tacke U et al.	The effect of tobacco smoking on subjective symptoms of inadequacy ("not holding") of methadone dose among opiate addicts in methadone maintenance treatment.
620	Taipale P, Heinonen S.	Trisomiaseulonnan nykytila.
621	Taipale P, Hiilesmaa V.	Predicting delivery date by ultrasound and last menstrual period in early gestation.
622	Takala J et al.	Nutrition support in trauma and sepsis.
623	Tammi R et al.	Hyaluronan enters keratinocytes by a novel endocytic route for catabolism.
624	Tanila H.	Noradrenergic regulation of hippocampal place cells.
625	Tanner SM et al.	BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia.
626	Tanskanen A et al.	Fish consumption, depression, and suicidality in a general population.
627	Tanskanen A et al.	Fish consumption and depressive symptoms in the general population in Finland.
628	Tanskanen A et al.	Nightmares as predictors of suicide.
629	Tanskanen A, Viinamäki H.	Drs. Tanskanen and Viinamäki reply.
630	Tapiola T.	Biological Markers for Alzheimer´s Disease.
631	Tapiola T et al.	CSF tau and Abeta42 levels in patients with Down´s syndrome.
632	Tarkiainen R et al.	Lapsiperheiden varhaisen tuen työmenetelmiä. Pienryhmätoiminta lapsiperheiden tukena: videoidut palautekeskustelut pienryhmätoiminnasta.
633	Tarkka IM.	Cerebral sources of electrial potentials related to human vocalization and mouth movement.
634	Tarkka IM et al.	Altered frontal lobe function suggested by source analysis of event-related potentials in impulsive violent alcoholics.
635	Tarvainen MP et al.	Analysis of galvanic skin responses with principal components and clustering techniques.
636	Taskinen T.	Moisture and Mould Problems in School Buildings.
637	Taskinen T et al.	Mold-specific IgE antibodies in relation to exposure and skin test data in schoolchildren.
638	Tenhunen JJ et al.	Gut luminal lactate release during gradual intestinal ischemia.
639	Tenhunen JJ et al.	Gastric mucosal systemic partial pressure of carbon dioxide (PCO2) gradient in experimental endotoxin shock in swine - comparison of two methods.
640	Teräsvirta M, Saari KM.	Mykiö ja sen sairaudet.
641	The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigato.	Effects of clopidogrel in addition to aspirin in patietns with acute coronary syndromes without st-segment elevation.
642	The DECODE Study Group on behalf of the European Diabetes Epidemiology Group.	Glucose tolerance and cardiovascular mortality.
643	The GUSTO V Investigators.	Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy of combination reduced fibrinolytic therapy and platelet glucoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
644	Tiainen S.	Informaatioteknologiaa terveydenhuollon ammattilaisille.
645	Tiihonen J.	Recidivistic violent behavior and axis I and axis II disorders.
646	Tiihonen J.	Oikeuspsykiatria.
647	Tiihonen J et al.	Free L-tryptophan plasma levels in antisocial violent offenders.
648	Tikka T et al.	Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.
649	Tikka T et al.	Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic, protect neurons against apoptosis induced by ionizing radiation.
650	Tikka TM, Koistinaho JE.	Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia.
651	Timonen M et al.	Association between atopic disorders and depression: findings from the Northern Finland 1966 birth cohort study.
652	Tommiska V et al.	A national short-term follow-up study of extremely low birth weight infants born in Finland in 1996-1997.
653	Torkko P et al.	Characterization of Mycobacterium bohemicum isolated from human, veterinary and environmental sources.
654	Tuhkanen K et al.	Two-year follow-up results of a prospective randomized trial comparing hybrid laser prostatectomy with TURP in the treatment of big benign prostates.
655	Tukiainen H.	Rintaan koskee - syy keuhkoissa?
656	Tuomainen R.	Terveyden palvontaan - medikalisaation luomat uhkavisiot.
657	Tuomainen R et al.	Selvitysmieshanke sairaalassa - prosessi ja opetuksia.
658	Tuomainen R, Tuomainen M.	Mikä maksaa - sairaanhoitopiirien vertailua benchmarking-tiedoin.
659	Tuomilehto J et al.	Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study.
660	Tuomilehto J et al.	Authors's reply (Sodium excretion and cardiovascular mortality).
661	Tuomilehto J et al.	Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance .
662	Tuomisto L et al.	Changes in circadian rhythmicity and melatonin balance in rats with portacaval anastomosis (PCA) - relation with histamine.
663	Tupala E et al.	Dopamine D2/D3-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics.
664	Tupala E et al.	Measurement of the striatal dopamine transporter density and heterogeneity in type 1 alcoholics using human whole hemisphere autoradiography.
665	Tupola S et al.	Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus.
666	Töyry E.	Hoidon ihmisläheisyys erikoissairaanhoidossa. Mittarin kehittäminen ja käyttö.
667	Töyry E, Vehviläinen-Julkunen K.	Developing an instrument for the measurement of humane caring.
668	Töyräs J.	Mechano-Acoustic Characterization of Articular Cartilage and Trabecular Bone.
669	Töyräs J et al.	Estimation of the Young's modulus of articular cartilage using an arthroscopic indentation instrument and ultrasonic measurement of tissue thickness.
670	Udd M et al.	Regular-dose versus high-dose omeprazole in peptic ulcer bleeding.
671	Uusimaa P et al.	Vasoactive peptides and procollagen propeptides in patients with hypertension in relation to cardiac hypertrophy and diastolic heart failure: design of the study and patient characteristics.
672	Uusitalo ALT.	Making a difficult diagnosis and implementing targeted treatment .
673	Uusitupa M.	Liikunta ja ruokavalio ovat metabolisen oireyhtymän täsmähoitoa.
674	Uusitupa M.	Aikuistyypin diabeteksen ehkäisy - haaste terveydenhuollollemme.
675	Uusitupa M, Tuomainen R.	Yhteistyö sairaanhoitopiirien välillä Suomessa.
676	Vaag A et al.	Metabolic impact of a family history of type 2 diabetes. Results from a European multicentre study (EGIR).
677	Valkamo M et al.	Alexithymia in patients with coronary heart disease.
678	Valkamo M et al.	Depression and associated factors in coronary heart disease.
679	Valkamo M et al.	Psychiatric morbidity and the presence and absence of angiographic coronary disease in patients with chest pain.
680	Valkonen-Korhonen M et al.	Loss of time-organized sympathetic skin responses in acute psychosis.
681	Valle TT et al.	Tyypin 2 diabetes on ehkäistävissä elämäntapamuutoksilla.
682	Valtonen HJ et al.	Tegmental defects and cerebrospinal fluid otorrhea.
683	Valve R.	Studies on Genetic Regulation of Basal Metabolic Rate in Obese Subjects.
684	Vanamo K, Kiekara O.	Pylephlebitis after appendicitis in a child.
685	Vanamo T et al.	Intra-familial child homicide in Finland 1970-1994: incidence, causes of death and demographic characteristics.
686	Vandenberghe S et al.	Iterative reconstruction algorithms in nuclear medicine.
687	Vanhala R et al.	Low levels of insulin-like growth factor-I in cerebrospinal fluid in children with autism.
688	Vanhanen M et al.	APOE-epsilon4 is associated with weight loss in women with AD . A population-based study.
689	Vanhatalo S et al.	Reversed visual field constrictions in children after vigabatrin withdrawal-true retinal recovery or improved test performance only?
690	Vanhatalo S, Riikonen R.	Nitric oxide metabolites, nitrates and nitrites in the cerebrospinal fluid in children with west syndrome.
691	Vapaavuori J.	Dialoginen muutos ryhmäkeskusteluissa: työyhteisön jumi konsultaation kohteena.
692	Vapalahti M.	Comments (to Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrgage: a problem of neurointensive care).
693	Vapalahti M.	Comment to (Surgical treatment of chronic subdural hematoma based on intrahematomal membrane structure on MRI).
694	Vapalahti M.	Comment to (Radiologically confirmed de novo glioblastoma multiforme and hippocampal sclerosis associated with the first onset of nonconvulsive simple partial status.
695	Vapalahti M.	Comment to (Metastatic brain tumours from oesophageal carcinoma: Neuro-imaging and clinicopathological characteristics in Japanese patients).
696	Vapalahti M.	Comment to (A scanning technique to measure regional cerebral blood flow and oxyhemoglobin level).
697	Vapalahti M.	Comment to (The influence of apolipoprotein E genotype on outcome after spontaneous subarachnoid hemorrhage: a preliminary study.
698	Vapalahti M.	Comment to (Role of adenosine 5'-triphosphate in vasospasm after subarachnoid hemorrhage: human investigations).
699	Vartiainen N et al.	Piroxicam and NS-398 rescue neurones from hypoxia/reoxygenation damage by a mechanism independent of cyclo-oxygenase inhibition.
700	Vauhkonen I.	Early Defects in Glucose Metabolism in Relatives of Patients with Different Phenotypes of Diabetes Mellitus.
701	Venesmaa PK et al.	Monitoring of periprosthetic BMD after uncemented total hip arthroplasty with dual-energy X-ray absorptiometry - a 3-year follow-up study.
702	Venesmaa PK et al.	Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: A prospective randomized study.
703	Vesala H-H.	Laskentamalli ja sovellusesimerkkejä.
704	Vesala H-H.	Filmiarkistosta digitaaliarkistoon: Itä-Suomi.
705	Vesala H-H.	PACS:n tärkein tavoite on parantaa potilaan hoitoa.
706	Vesala H-H.	Filmiarkistointiin käytetty työaika ja palkkakustannukset.
707	Vesala H-H et al.	Perinteisestä filmikuvantamisesta digitaalikuvantamiseen.
708	Vesala H-H et al.	Mitä vaikuttaa siirtyminen röntgenfilmiarkistoinnista digitaaliarkistointiin.
709	Vessby B et al.	Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women:The KANWU study.
710	Videman T et al.	The relative roles of intragenic polymorphisms of the vitamin D receptor gene in lumbar spine degeneration and bone density.
711	Viinamäki H et al.	Masennuspotilaat psykiatrisessa osastohoidossa.
712	Viinamäki H et al.	Pitkäaikaiseen masentuneisuuteen liittyvät tekijät yleisväestössä.
713	Viitanen L.	Studies on the Genetic Basis of Premature Coronary Heart Disease Using Candidate Gene Approach and Genome-Wide Scanning.
714	Viitanen L et al.	Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease.
715	Viitanen L et al.	Apolipoprotein E gene promoter (-219G/T) polymorphism is associated with premature coronary heart disease.
716	Viramo P, Sulkava R.	Muistihäiriöiden ja dementian epidemiologia.
717	Virtanen T.	Lipocalin allergens.
718	Virtaniemi JA et al.	Surgical management of irradiation failures in T1-T2 squamous cell carcinoma of the glottic larynx.
719	Virtaniemi JA et al.	The incidence and etiology of postlaryngectomy pharyngocutaneous fistulae.
720	Vornanen M, Jantunen E.	T-solulymfoomat: WHO:n luokitus, kliiniset piirteet ja hoitoperiaatteet.
721	Voutilainen-Kaunisto R.	Aikuistyypin diabetekseen liittyvät silmänpohjamuutokset ja riskitekijät.
722	Voutilainen-Kaunisto R.	Ocular Manifestations in Type 2 Diabetes. Controlled Ten-Year Follow-Up Study.
723	Voutilainen-Kaunisto R et al.	Maculopathy and visual acuity in newly diagnosed type 2 diabetic patients and non-diabetic subjects: A 10-year follow-up study.
724	Voutilainen-Kaunisto RM et al.	Occurrence and predictors of retinopathy and visual acuity in type 2 diabetic patients and control subjects 10-year follow-up from the diagnosis.
725	Vuorio AF et al.	Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences.
726	Vuoristo M-S et al.	Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma.
727	Väisänen M et al.	Leikkauksen jälkeinen kipu vaihtelee lapsen mukaan.
728	Välimäki MJ et al.	Lasten riisitaudista aikuisten osteomalasiaan.
729	Välimäki S et al.	Relation of collagen type I alpha 1 (COLIA1) and vitamin D receptor genotypes to bone mass, turnover, and fractures in early postmenopausal women and to hip fractures in elderly people.
730	Väätäinen U.	Poikkitankokiinnitys eturistisiteen kirurgiassa. Alustavat tulokset.
731	Väätäinen U.	Nivelkierukan siirre. Indikaatiot ja tulokset.
732	Wahlfors J et al.	Green fluorescent protein (GFP) fusion constructs in gene therapy research.
733	Waldemar G et al.	Benefits of donepezil on cognition, function and neuropsychiatric symptoms in patients with mild and moderate Alzheimr´s disease over one year.
734	Wang H et al.	New amino acid substitutions in the IRS-2 gene in Finnish and Chinese subjects with late-onset type 2 diabetes.
735	Wangel M et al.	WWW--an effective way of teaching radiology.
736	Wedel H et al.	Challenges of subgroup analyses in multinational clinical trials: Experiences from the MERIT-HF trial.
737	Wilhelmsen L et al.	Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S): Impact of predicted risk on the benefit of cholesterol-lowering treatment.
738	Winblad B et al.	A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.
739	Wood D et al.	Rapid assessment of chest pain: The rationale is clear, but evidence is needed.
740	Ylinen A et al.	Kognitiivisten toimintojen neurobiologinen tausta.
741	Ylinen A, Kanto-Ronkanen A.	Seizure-Warning systems and protective adjustments.
742	Ylinen J et al.	Kuntoutustarve lannerangan välilevytyräleikkauksen jälkeen.
743	Ylinen J et al.	Kirjoittajien vastine edelliseen (Kuntoutustarve lannerangan välilevytyräleikkauksen jälkeen).
744	Ylitalo K et al.	Reversible ischemic inhibition of F1F0-ATPase in rat and human myocardium.
745	Ylitalo K et al.	Evidence suggesting coronary vasodilation as the principal mechanism in the warm-up phenomenon.
746	Ylitalo K, Peuhkurinen K.	Tuumorinekroositekijä alfa ja sydän - voidaanko sydänsairauksia hoitaa sytokiineja neutraloimalla?
747	Ylitalo K, Peuhkurinen K.	Clinical relevance of ischemic preconditioning.
748	Ylä-Herttuala S.	Geeniterapia.
749	Ylä-Herttuala S.	Gene therapy for coronary heart disease.
750	Zhou J et al.	Inverse T2 contrast at 1.5 tesla between gray matter and white matter in the occipital lobe of normal adult human brain.
751	Äikiä M et al.	Verbal memory in newly diagnosed patients and patients with chronic left temporal lobe epilepsy.
752	Ågren JJ et al.	Postprandial responses of individual fatty acids in subjects homozygous for the threonine- or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene 1,2.
753	Åmark P et al.	Risk prevention in daily life.
754	Örmälä T et al.	T cells of the colonic mucosa in patients with infantile colitis.

Kuopion yliopistollinen sairaala	Kuopio University Hospital
Julkaisutietokanta 15.1.2003	Publications Data Base 15.1.2003

Kuopion yliopistollinen sairaalaKuopio University Hospital

Julkaisut 2001Publications 2001

Kuopion yliopistollinen sairaala
Kuopio University Hospital

Julkaisut 2001
Publications 2001